J&J
J&J must pay $572 million for fuelling opioid crisis in Oklahoma, judge says
August 27, 2019Manufacturing and Production J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, opioids, pharma
A judge in Oklahoma has said that Johnson & Johnson must pay $572 million for the part it played in …
Oklahoma lawyers say J&J is kingpin of pharmaceutical cartel
July 16, 2019Manufacturing and Production J&J, JJ, Oklahoma, opioid crisis, opioids, pharma
Lawyers representing the State of Oklahoma described Johnson & Johnson as the ‘kingpin’ in a ‘pharmaceutical cartel’ as they accused …
Top Ten most popular articles on Pharmafile.com this week!
June 14, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, GSK, J&J, JJ, Otsuka, Pfizer, Purdue, Sanofi, Vertex, pharma
Pfizer supressed research showing their arthritis drug Enbrel reduced the risk of Alzheimer’s. This was the big revelation this week! …
J&J and Colgate pay $4.8 million each to woman in California
June 13, 2019Business Services, Medical Communications Cancer, J&J, JJ, lawsuit, pharma, talc
A California court has said Johnson & Johnson and Colgate-Palmolive must pay a total of nearly $10 million to a …
J&J ‘worse’ than Purdue Pharma expert witness says
June 12, 2019Research and Development J&J, JJ, Johnson & Johnson, Oklahoma, opioid crisis, phamra
The role Johnson & Johnson played in the opioid crisis was ‘in some ways worse’ than that of Purdue Pharma, …
Healthcare would be ‘on the table’ in post-Brexit trade negotiations with US, Trump’s ambassador says
June 3, 2019Sales and Marketing J&J, JJ, NHS, UK, US, brexit, healthcare
The American Ambassador to the United Kingdom has said that Britain’s healthcare system would be ‘on the table’ in post-Brexit …
Oklahoma prosecutors say J&J used ‘brainwashing campaign’ to boost opioid sales
May 30, 2019Research and Development J&J, JJ, opioid crisis, opioids, pharma, public health
Oklahoma state prosecutors have accused Johnson & Johnson of engaging in a “cynical, deceitful, multibillion-dollar brainwashing campaign” to boost sales …
Top Ten most popular articles on Pharmafile.com this week
May 24, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Gilead, J&J, JJ, MSD, Sandoz, pharma, top ten
On the day that UK Prime Minister Theresa May announces her resignation, we look back on the week’s biggest stories …
Top Ten most popular articles on Pharmafile.com this week!
May 17, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Gilead, J&J, JJ, Janssen, Mundipharma, Novartis, Teva, generics
Some big names – including Gilead, Janssen, Teva and Bristol-Myers Squibb – were in trouble this week after two separate …
J&J to invest €100 million into Limerick manufacturing facilities creating 100 new jobs
May 16, 2019Manufacturing and Production Ireland, J&J, JJ, Limerick, medical technology, pharma
Healthcare conglomerate Johnson & Johnson has said it will be investing €100 million into the expansion of its Vision Care …
Top Ten most popular articles on Pharmafile.com this week!
April 26, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Aduro Biotech, Cancer, GSK, ICR, J&J, JJ, Novartis, Sandoz, pharma
The Institute for Cancer Research (ICR) called for new measures to increase the speed with which patients in the UK …
J&J pay $9.9 million to settle surgical mesh implant case
April 23, 2019Manufacturing and Production . Johnson & Johnson, J&J, JJ, Johnson & Johnson, Litigation, washington
Healthcare conglomerate Johnson & Johnson has agreed to pay $9.9 million to settle a Washington state lawsuit over the firm’s …
Janssen closes plant in California, 49 positions axed
April 3, 2019Manufacturing and Production, Research and Development J&J, JJ, Janssen, Johnson & Johnson, Vacaville, california
Janssen are letting go of 49 employees due to the closure of their plant in Vacaville, California. The Johnson & …
Indian authorities say J&J’s baby shampoo contains ‘harmful ingredients’
April 1, 2019Sales and Marketing Cancer, India, J&J, JJ, Johnson & Johnson, Rajasthan, baby shampoo, formaldehyde
Indian authorities in the state of Rajasthan have said that samples taken from Johnson & Johnson’s baby shampoo contained ‘harmful …
J&J’s antihistamine-releasing contact lens shows promise in Phase 3 trials
March 28, 2019Research and Development J&J, JJ, eye care, pharma
Johnson and Johnson has unveiled new Phase 3 data on its antihistamine-releasing contact lens, showing that the investigational product led …
Latest content
